Atea Pharmaceuticals, Inc. (AVIR)
Since May 13, 2021, Atea Pharmaceuticals, Inc. (AVIR) has reported earnings 21 times. On average the shares move ±7.37% post-earnings, with a positive reaction 38.1% of the time. Its largest post-earnings gain was +19.2% (May 13, 2021) and its largest decline was -16.94% (May 12, 2026). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings reactions
How AVIR moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±7.37%
Positive %
38.1%
Negative %
61.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 12, 2026 | ☽ POST | -16.94% | open_in_new |
| Mar 05, 2026 | ☽ POST | +11.13% | open_in_new |
| Nov 12, 2025 | ☽ POST | -12.57% | open_in_new |
| Aug 07, 2025 | ☽ POST | -2.31% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±7.37%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260623 | open_in_new SEC.gov |
| 4 | 20260623 | open_in_new SEC.gov |
| 4 | 20260623 | open_in_new SEC.gov |
| 4 | 20260623 | open_in_new SEC.gov |
| 4 | 20260623 | open_in_new SEC.gov |
| 4 | 20260623 | open_in_new SEC.gov |
| 4 | 20260623 | open_in_new SEC.gov |
| 4 | 20260623 | open_in_new SEC.gov |
| 8-K | 20260622 | open_in_new SEC.gov |
| 4/A | 20260521 | open_in_new SEC.gov |
Frequently asked about AVIR earnings
When does Atea Pharmaceuticals, Inc. report earnings next? expand_more
Atea Pharmaceuticals, Inc. (AVIR)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does AVIR stock move after earnings? expand_more
Over 21 reports, AVIR has moved an average of ±7.37% the session after earnings, closing higher 38.1% of the time.
What was AVIR's biggest post-earnings move? expand_more
AVIR's largest post-earnings gain on record was +19.2% on May 13, 2021, and its largest decline was -16.94% on May 12, 2026.
Where can I find Atea Pharmaceuticals, Inc.'s SEC filings? expand_more
All of Atea Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALAMO GROUP INC (ALG) earnings 2026-08-04
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04
- ProFrac Holding Corp. (ACDC) earnings 2026-08-07